These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 463670)

  • 1. Approaches to effective tumor immunotherapy with cells and the enzyme neuraminidase.
    Sedlacek HH; Bengelsdorff HJ; Lemmer A; Seiler FR
    Adv Exp Med Biol; 1979; 114():789-94. PubMed ID: 463670
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.
    Simmons RL; Rios A
    Johns Hopkins Med J Suppl; 1974; 3():75-84. PubMed ID: 4536589
    [No Abstract]   [Full Text] [Related]  

  • 3. Spontaneous mammary tumors in mongrel dogs. A relevant model to demonstrate tumor therapeutical success by application of neuraminidase-treated tumor cells.
    Sedlacek HH; Seiler FR
    Dev Biol Stand; 1977 Apr 13-15; 38():399-412. PubMed ID: 608530
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.
    Simmons RL; Rios A
    Transplant Proc; 1975 Jun; 7(2):247-51. PubMed ID: 1129845
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor therapy of neoplastic diseases with tumor cells and neuraminidase. Further experimental studies on chessboard vaccination in canine mammary tumors.
    Sedlacek HH; Hagmayer G; Seiler FR
    Cancer Immunol Immunother; 1986; 23(3):192-9. PubMed ID: 3791304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active specific immunotherapy of minimal residual tumor: excision plus neuraminidase-treated tumor cells.
    Rios A; Simmons RL
    Int J Cancer; 1974 Jan; 13(1):71-81. PubMed ID: 4818273
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental cancer immunotherapy: modification of tumor cells to increase immunogenicity.
    Rios A; Simmons RL
    Ann N Y Acad Sci; 1976; 276():45-60. PubMed ID: 68699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possibilities of immunologic management of Brown-Pearce carcinoma in rabbits].
    Gericke D; Hofstetter A; Keiditsch E; Lersch C
    Onkologie; 1983 Feb; 6(1):36-43. PubMed ID: 6405336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental and clinical trials with BCG immunotherapy.
    Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
    Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
    [No Abstract]   [Full Text] [Related]  

  • 10. Regression of spontaneous mammary carcinomas using direct injections of neuraminidase and BCG.
    Simmons RL; Rios A; Kersey JH
    J Surg Res; 1972 Feb; 12(2):57-61. PubMed ID: 4111004
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuraminidase and tumor immunotherapy.
    Sedlacek HH; Seiler FR; Schwick HG
    Klin Wochenschr; 1977 Mar; 55(5):199-214. PubMed ID: 846180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuraminidase treated cells and their role in cancer immunotherapy.
    Simmons RL; Rios A
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuraminidase immunotherapy of tumors in man.
    Rosato FE; Brown AS; Miller EE; Rosato EF; Mullis WF; Johnson J; Moskovitz A
    Surg Gynecol Obstet; 1974 Nov; 139(5):675-82. PubMed ID: 4428323
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro evidence that Vibrio Cholerae neuraminidase increases antigenicity of sarcoma cells.
    Faraci RP; Ketcham AS
    Surg Forum; 1974; 25(0):99-101. PubMed ID: 4439267
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of neuraminidase in experimental immunotherapy of two murine pulmonary carcinomas.
    Alley CD; Snodgrass MJ
    Cancer Res; 1977 Jan; 37(1):95-101. PubMed ID: 830425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface modification in the treatment of experimental cancer: neuraminidase or concanavalin A.
    Simmons RL; Rios A
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1541-7. PubMed ID: 4138077
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential effect of neuraminidase on the immunogenicity of viral associated and private antigens of mammary carcinomas.
    Simmons RL; Rios A
    J Immunol; 1973 Dec; 111(6):1820-5. PubMed ID: 4750868
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of treatment with neuraminidase on the immunogenicity of ATPC tumor cells].
    Iorio AM; Rivosecchi P; Santoni A; Fabiani L
    Boll Soc Ital Biol Sper; 1973 Mar; 49(9):462-6. PubMed ID: 4787510
    [No Abstract]   [Full Text] [Related]  

  • 19. Possible immunological action of Vibrio cholerae neuraminidase (VCN) in tumor immunotherapy.
    Sedlacek HH; Johannsen R; Seiler FR
    Dev Biol Stand; 1977 Apr 13-15; 38():387-98. PubMed ID: 608528
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental cancer immunotherapy using a neuraminidase-treated non-viable frozen tumor vaccine.
    Rios A; Simmons RL
    Surgery; 1974 Apr; 75(4):503-7. PubMed ID: 4840798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.